社会脆弱性对非小细胞肺癌初期阶段和治疗的影响
Christina M Stuart1, Adam R Dyas1, Michael R Bronsert2
1Department of Surgery, The University of Colorado, Anschutz Medical Campus, Aurora CO, USA.
Lung cancer (Amsterdam, Netherlands)
|January 4, 2024
概括
社会脆弱性指数 (SVI) 影响非小细胞肺癌 (NSCLC) 的表现和治疗. 高SVI患者在诊断时呈现先进阶段,手术建议减少,突出显示了癌症护理方面的差异.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 健康的社会决定因素
背景情况:
- 社会脆弱性指数 (SVI) 是理解健康的社会决定因素的关键指标.
- 医疗保健获取和结果的不平等往往与社会经济因素有关.
研究的目的:
- 调查社会脆弱性指数 (SVI) 对非小细胞肺癌 (NSCLC) 患者呈现阶段的影响.
- 为了确定SVI是否会影响NSCLC患者的后续治疗方式.
主要方法:
- 分析了来自国家癌症数据库 (2011-2021) 的1662名NSCLC患者的队列.
- 患者被分为低SVI (<75百分位) 和高SVI (>75百分位) 的两组.
- 用多变量逻辑回归来控制人口和瘤变量.
主要成果:
- 患有高SVI的患者更有可能是男性,非白人,有并发症,并且存在于较高的AJCC阶段 (T,M,总体).
- 高度脆弱的患者在更晚的阶段出现的几率是1.5倍.
- 高SVI与更低的外科推和接收的可能性有关,即使在调整后.
结论:
- 较高的社会脆弱性与NSCLC呈现的先进阶段有关.
- 患有高SVI的患者接受的手术建议和治疗较少,这表明潜在的不平等.
- 需要进一步的研究来解决这些差异,并促进公平的癌症护理.
更多相关视频
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
9.8K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Pulmonary Tuberculosis I
244
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
244
Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
